Health
Monoclonal Antibody Combo Treatment Reduces Viral Load in COVID – Medscape
Bamlanivimab and etesevimab together were associated with a statistically significant reduction in SARS-CoV-2. Bamlanivimab alone, however, showed no significant…
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.
A combination treatment of neutralizing monoclonal antibodies bamlanivimab and etesevimab was associated with a statistically significant reduction in SARS-CoV-2 at day 11 compared with placebo among nonhospitalized patients who had mild-to-moderate COVID-19, new data indicate.
However, bamlanivimab alone in three different single-infusion doses showed no significant reduction in viral load compared…
-
Business18 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
Noosa News17 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News15 hours agoTips to improve engagement – Proctor
-
General24 hours agoJordan Thompson retires from Wimbledon round-of-16 match with American Taylor Fritz